BIOA

BioAge Labs, Inc.$17.46-0.60 (-3.32%)

Prev Close$18.06·MCap$613.5M·P/E—·Vol257.9K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$10.91M

◆

Net Activity

Net Seller

$10.91M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at BioAge Labs, Inc. (BIOA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $10.91M. The most recent insider transaction was by RUBIN PAUL D (officer: Chief Medical Officer), who sold $150.9K worth of shares on Mar 3, 2026. BioAge Labs, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $613.5M.

BIOA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026	RUBIN PAUL D	officer: Chief Medical Officer	Sell	7,433	$20.30	$150.9K	0Exit
Feb 2, 2026	RUBIN PAUL D	Chief Medical Officer	Sell	7,433	$18.75	$139.4K	0
Jan 15, 2026	Fortney Kristen	director, officer: Chief Executive Officer	Sell	233,107	$18.12	$4.22M0.6% OS	976,949
Jan 15, 2026	GOLDSTEIN DOV A MD	officer: Chief Financial Officer	Sell	27,000	$19.70	$531.8K	40,434-40%
Jan 13, 2026	Fortney Kristen	Chief Executive Officer	Sell	233,107	$18.12	$4.22M0.6% OS	0
Jan 13, 2026	GOLDSTEIN DOV A MD	Chief Financial Officer	Sell	27,000	$19.70	$531.8K	0
Jan 6, 2026	RUBIN PAUL D	officer: Chief Medical Officer	Sell	7,433	$12.85	$95.5K	0Exit
Jan 2, 2026	RUBIN PAUL D	Chief Medical Officer	Sell	7,433	$12.85	$95.5K	0
Dec 9, 2025	RUBIN PAUL D	Chief Medical Officer	Sell	18,000	$12.00	$216.0K	0
Dec 4, 2025	RUBIN PAUL D	Chief Medical Officer	Sell	68,897	$10.19	$701.9K	0
Oct 1, 2024	Pande Vijay Satyanand	Director	Buy	219,195	$19.75	$4.33M0.6% OS	0
Sep 27, 2024	Barton Shane	Principal Accounting Officer	Buy	2,632	$18.00	$47.4K	0
Sep 27, 2024	Pande Vijay Satyanand	Director	Buy	900,000	$18.00	$16.20M2.5% OS	0
Sep 25, 2024	ENRIGHT PATRICK G	Director	Buy	400,000	$18.00	$7.20M1.1% OS	0
Sep 25, 2024	HEALY JAMES	Director	Buy	666,665	$18.00	$12.00M1.9% OS	0

BIOA Insider Buying Activity

The following table shows recent insider purchases of BioAge Labs, Inc. (BIOA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Oct 1, 2024	Pande Vijay Satyanand	Director	Buy	219,195	$19.75	$4.33M0.6% OS
Sep 27, 2024	Barton Shane	Principal Accounting Officer	Buy	2,632	$18.00	$47.4K
Sep 27, 2024	Pande Vijay Satyanand	Director	Buy	900,000	$18.00	$16.20M2.5% OS
Sep 25, 2024	ENRIGHT PATRICK G	Director	Buy	400,000	$18.00	$7.20M1.1% OS
Sep 25, 2024	HEALY JAMES	Director	Buy	666,665	$18.00	$12.00M1.9% OS

BIOA Insider Selling Activity

The following table shows recent insider sales of BioAge Labs, Inc. (BIOA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026	RUBIN PAUL D	officer: Chief Medical Officer	Sell	7,433	$20.30	$150.9K	0Exit
Feb 2, 2026	RUBIN PAUL D	Chief Medical Officer	Sell	7,433	$18.75	$139.4K	0
Jan 15, 2026	Fortney Kristen	director, officer: Chief Executive Officer	Sell	233,107	$18.12	$4.22M0.6% OS	976,949
Jan 15, 2026	GOLDSTEIN DOV A MD	officer: Chief Financial Officer	Sell	27,000	$19.70	$531.8K	40,434-40%
Jan 13, 2026	Fortney Kristen	Chief Executive Officer	Sell	233,107	$18.12	$4.22M0.6% OS	0
Jan 13, 2026	GOLDSTEIN DOV A MD	Chief Financial Officer	Sell	27,000	$19.70	$531.8K	0
Jan 6, 2026	RUBIN PAUL D	officer: Chief Medical Officer	Sell	7,433	$12.85	$95.5K	0Exit
Jan 2, 2026	RUBIN PAUL D	Chief Medical Officer	Sell	7,433	$12.85	$95.5K	0
Dec 9, 2025	RUBIN PAUL D	Chief Medical Officer	Sell	18,000	$12.00	$216.0K	0
Dec 4, 2025	RUBIN PAUL D	Chief Medical Officer	Sell	68,897	$10.19	$701.9K	0